Metisox

Metisox provides AI-driven translational safety intelligence for pharmaceutical and biotechnology R&D teams. Our mission is to enable safer, smarter drug discovery by combining expert biological curation with multi-omics analytics. What we do: • Target Safety Assessments (TSA) – expert-curated evaluations of novel drug targets, integrating mechanistic, genetic, and pathway data to identify on- and off-target risks. • Carcinogenicity Risk Assessments (CRA) – fully aligned with ICH S1B(R1) Weight-of-Evidence guidelines, helping oncology and safety teams modernize their preclinical strategy. •Proprietary technology platform for target safety / drug discovery – our proprietary multi-omics knowledgebase linking millions of curated biological, toxicological, and pathway relationships across species. • Custom bioinformatics & biomarker discovery – transforming complex data into actionable insights for translational safety and R&D. By uniting AI, systems biology, and expert toxicology, Metisox supports decision-making from target selection to IND — helping our partners reduce attrition and accelerate the development of safe, effective therapeutics. info@metisox.com